Valuation: Zai Lab Limited

Market Cap 2.86B 2.54B 2.38B 2.17B 4.08B 276B 4.14B 28.77B 11.14B 140B 10.75B 10.52B 451B P/E 2026 *
-11.5x
P/E 2027 * -11.5x
Enterprise Value 2.41B 2.14B 2B 1.82B 3.43B 232B 3.47B 24.17B 9.36B 118B 9.03B 8.83B 379B EV / Sales 2026 *
5.51x
EV / Sales 2027 * 4.5x
Free-Float
94.05%
Yield 2026 *
-
Yield 2027 * -
1 day-3.19%
1 week+0.87%
Current month-3.19%
1 month+0.79%
3 months+33.16%
6 months+25.37%
Current year+44.56%
1 week 25.06
Extreme 25.06
26.68
1 month 23.64
Extreme 23.64
27.14
Current year 15.96
Extreme 15.96
27.5
1 year 15.96
Extreme 15.96
34.07
3 years 13.48
Extreme 13.48
44.34
5 years 13.48
Extreme 13.48
107.98
10 years 13.48
Extreme 13.48
193.54
Manager TitleAgeSince
Chief Executive Officer 61 01/04/2014
Director of Finance/CFO 58 07/07/2023
President 62 01/12/2022
Director TitleAgeSince
Chairman 61 01/04/2014
Director/Board Member 83 01/01/2017
Director/Board Member 75 01/01/2017
Date Insider Type Main position Quantity % Market Cap. Importance
8/19/26 A Sell

Chief Financial Officer

-260 0.0000%
8/14/26 A Exercice

Chief Financial Officer

2,927 0.0003%
8/12/26 A Other

Director

-85,060 0.0075%
Change 5-day change 1-year change 3-year change Capi.($)
-3.19%+0.87%-25.96%+4.90% 2.96B
-0.62%-2.71%+39.30%+114.07% 1,031B
-2.30%-4.44%+39.03%+66.07% 638B
-0.63%-1.96%+6.36%+74.38% 462B
-1.03%-2.82%+59.56%+39.69% 359B
-0.03%-3.96%+23.63%+39.35% 335B
-1.58%-0.76%+13.50%+25.77% 273B
-2.02%-2.97%-3.25%+8.38% 253B
-3.38%+0.30%+36.44%+51.54% 228B
-1.04%-1.46%+32.70%+96.82% 185B
Average -1.58%-1.33%+22.13%+52.10% 376.68B
Weighted average by Cap. -1.25%-1.89%+30.47%+69.13%

Financials

2026 *2027 *
Net sales 436M 388M 363M 330M 622M 42.02B 631M 4.39B 1.7B 21.4B 1.64B 1.6B 68.74B 552M 490M 459M 418M 787M 53.16B 798M 5.55B 2.15B 27.07B 2.07B 2.03B 86.96B
Net income -241M -214M -200M -182M -343M -23.17B -348M -2.42B -936M -11.8B -904M -884M -37.9B -211M -187M -175M -160M -301M -20.32B -305M -2.12B -821M -10.35B -792M -775M -33.24B
Net Debt -458M -406M -380M -346M -652M -44.06B -661M -4.6B -1.78B -22.44B -1.72B -1.68B -72.08B -381M -338M -316M -288M -543M -36.67B -550M -3.83B -1.48B -18.67B -1.43B -1.4B -59.98B
Logo Zai Lab Limited
Zai Lab Ltd is a holding company primarily engaged in biopharmaceutical business. The Company is focused on discovering, developing, and commercializing products that address medical conditions with significant unmet needs in the areas of oncology, immunology, neuroscience, and infectious disease. The Company has a series of patented drug candidates from the discovery stage to the late clinical project, including ZEJULA, OPTUNE, QINLOCK, NUZYRA and VYVGART, and others. The Company conducts its businesses within domestic and overseas markets.
Employees
1,784
Date Price Change Volume
01/10/26 $25.50 -3.19% 545,227
30/09/26 $26.34 +1.58% 830,830
29/09/26 $25.93 +0.93% 549,095
28/09/26 $25.69 +2.84% 884,778
25/09/26 $24.98 -1.19% 299,900
Trader
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
25.50USD
Average target price
33.14USD
Spread / Average Target
+29.96%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ZLAB Stock